Zhejiang Shengda Pharm - Asset Resilience Ratio
Zhejiang Shengda Pharm (603079) has an Asset Resilience Ratio of 1.46% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Zhejiang Shengda Pharm current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2025)
This chart shows how Zhejiang Shengda Pharm's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 603079 total assets.
Liquid Assets Composition Over Time
This chart breaks down Zhejiang Shengda Pharm's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Zhejiang Shengda Pharm debt and liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥32.02 Million | 1.46% |
| Total Liquid Assets | CN¥32.02 Million | 1.46% |
Asset Resilience Insights
- Limited Liquidity: Zhejiang Shengda Pharm maintains only 1.46% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Zhejiang Shengda Pharm Industry Peers by Asset Resilience Ratio
Compare Zhejiang Shengda Pharm's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Beijing Tongrentang Co Ltd
SHG:600085 |
Drug Manufacturers - Specialty & Generic | 2.51% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Shenzhen Kangtai Biological Products Co Ltd
SHE:300601 |
Drug Manufacturers - Specialty & Generic | 12.99% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
|
Sun Pharma Advanced Research Company Limited
NSE:SPARC |
Drug Manufacturers - Specialty & Generic | 0.64% |
|
ChengDa Pharmaceuticals Co. Ltd.
SHE:301201 |
Drug Manufacturers - Specialty & Generic | 32.14% |
Annual Asset Resilience Ratio for Zhejiang Shengda Pharm (2017–2025)
The table below shows the annual Asset Resilience Ratio data for Zhejiang Shengda Pharm.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 8.28% | CN¥182.06 Million ≈ $26.64 Million |
CN¥2.20 Billion ≈ $321.72 Million |
+8.28pp |
| 2024-12-31 | 0.00% | CN¥14.73K ≈ $2.16K |
CN¥1.79 Billion ≈ $261.25 Million |
-0.17pp |
| 2023-12-31 | 0.18% | CN¥3.01 Million ≈ $440.97K |
CN¥1.72 Billion ≈ $251.57 Million |
+0.17pp |
| 2021-12-31 | 0.00% | CN¥14.41K ≈ $2.11K |
CN¥1.76 Billion ≈ $258.25 Million |
-1.20pp |
| 2018-12-31 | 1.20% | CN¥15.02 Million ≈ $2.20 Million |
CN¥1.25 Billion ≈ $183.31 Million |
-7.93pp |
| 2017-12-31 | 9.13% | CN¥90.00 Million ≈ $13.17 Million |
CN¥985.98 Million ≈ $144.28 Million |
-- |
About Zhejiang Shengda Pharm
Zhejiang Shengda Bio-Pharm Co., Ltd. develops, produces, and sells food and feed additives for pharmaceutical, nutritional, food, and animal feed industry. It offers vitamins, such as biotin and folic acid; biological preservatives, including nisin, polylysine, and natamycin; and intermediate APIs. The company was incorporated in 1999 and is headquartered in Tiantai, China.